Feinstein Institutes Researchers Identify Potential Drug to Treat Sepsis

MANHASSET, N.Y.–(BUSINESS WIRE)–Each year, more than 48 million cases of sepsis are diagnosed and account for 11 million deaths annually. Current sepsis treatment is limited; to address this clinical need researchers from the Feinstein Institutes for Medical Research and Northwell Health’s Department of Pediatrics and Cohen Children’s Medical Center published new research in the journal … [Read more…]

Ambry Genetics Publishes 43,000 Patient Study Showing Combined RNA and DNA Analysis Identifies Patients Who Are High-Risk for Cancer but Would Have Been Missed by DNA Testing Alone

The largest RNA study ever conducted in hereditary cancer analyzed more than 43,000 patients who received Ambry’s +RNAinsight™ testing and found that 1 in 950 had an elusive clinically actionable result that would have been missed by DNA-only testing. Combined DNA and RNA testing identified cancer risk in an additional 1 out of 79 patients … [Read more…]

Wenzel Spine Announces the Launch of the S-LIF Procedure: Prioritizing Surgical Minimalism for Outpatient Spine Fusion

AUSTIN, Texas–(BUSINESS WIRE)–Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions for the treatment of spinal disorders, today announced the launch of the S-LIF Procedure for Stand-alone Lumbar Interbody Fusion using the VariLift®-LX device, the only stand-alone expandable posterior lumbar interbody fusion device that is FDA-cleared for 1 … [Read more…]

Exome Asset Management Shortlisted for HFM’s Sector Specialist and Emerging Market Fund Awards

NEW YORK–(BUSINESS WIRE)–Exome Asset Management (“Exome”), an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, today announced it has been shortlisted for the HFM US Performance Awards 2022 for both Sector Specialist and Emerging Market Fund. The HFM US Performance Awards are one of the most important and … [Read more…]

WestFax Announces New Integration With PaperCut

GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–#cloudfax–WestFax announced today the launch of its new fax integration for PaperCut MF. It’s the first time a third-party fax provider has worked with PaperCut’s Developer Relations team to create a custom plug-in for the PaperCut MF platform. “WestFax is excited to offer this new integration option with PaperCut,” says Barry Clark, … [Read more…]

Europe Ophthalmic Drug Delivery System Market to Grow at 6.4% Through 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Europe Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. Europe ophthalmic drug delivery system market was valued at $3,856.3 million in 2021 and will grow by 6.4% annually over 2021-2031, driven by the growing prevalence … [Read more…]

Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy

MILPITAS, Calif.–(BUSINESS WIRE)–#Bioproduction–Applied StemCell, Inc. (ASC), a leading cell and gene therapy CRO/CDMO focused on supporting the research community and biotechnology industry for their needs in developing and manufacturing cell and gene products, today announced the expansion of its Current Good Manufacturing (cGMP) facility. ASC has successfully carried out cell banking and product manufacturing projects … [Read more…]

Phase 3 Study to Be Initiated for Second Long-acting Injectable Antipsychotic Using MedinCell’s Technology

MONTPELLIER, France–(BUSINESS WIRE)–Teva Pharmaceuticals has notified MedinCell (Paris:MEDCL) that it made the decision to initiate the clinical Phase 3 trial for mdc‑TJK. MedinCell will receive immediately a $3 million payment from Teva Pharmaceuticals linked to the project development milestone. The Phase 3 study will assess the efficacy and safety of potentially the first subcutaneous long-acting … [Read more…]

Primary Ciliary Dyskinesia Epidemiology and Market Report 2022-2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Primary Ciliary Dyskinesia – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. The Primary Ciliary Dyskinesia market report provides current treatment practices, emerging drugs, Primary Ciliary Dyskinesia market share of the individual therapies, current and forecasted Primary Ciliary Dyskinesia market Size from 2019 to 2032 segmented by … [Read more…]

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Epidemiology and Market Forecast 2022-2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. The Skin And Skin Structure Infections (SSSI) Caused By Bacteria market report provides current treatment practices, emerging drugs, Skin And Skin Structure Infections (SSSI) Caused By Bacteria market share … [Read more…]